The risk or severity of adverse effects can be increased when Salsalate is combined with flumethasone.


The risk or severity of adverse effects can be increased when allopurinol is combined with Bendamustine.


The risk or severity of adverse effects can be increased when propofol is combined with prilocaine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when felbamate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Tolcapone is combined with papaverine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nifedipine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when butenafine is combined with Amrinone.


The risk or severity of adverse effects can be increased when cerulenin is combined with nimodipine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when oxaliplatin is combined with topotecan.


The risk or severity of adverse effects can be increased when alclofenac is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when alclofenac is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when nitrendipine is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with sulpiride.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when indomethacin is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with lidocaine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with pentazocine.


The risk or severity of adverse effects can be increased when tizanidine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Icatibant.


The risk or severity of adverse effects can be increased when amcinonide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amcinonide is combined with memantine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with terazosin.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when clorazepate is combined with Etidocaine.


The risk or severity of adverse effects can be increased when propranolol is combined with nicotine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when nalbuphine is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when tubocurarine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Telmisartan is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ondansetron.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with tiagabine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with cocaine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with zonisamide.


The risk or severity of adverse effects can be increased when ketamine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Icatibant.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Aclidinium is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when Tolcapone is combined with METAXALONE.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with papaverine.


The risk or severity of adverse effects can be increased when morphine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with nifedipine.


The risk or severity of adverse effects can be increased when methadone is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Carbetocin is combined with hydralazine.


The risk or severity of adverse effects can be increased when amobarbital is combined with ethosuximide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when amobarbital is combined with thiopental.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with trandolapril.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when pentazocine is combined with oxazepam.


The risk or severity of adverse effects can be increased when mesalamine is combined with amcinonide.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when mesalamine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Temsirolimus is combined with cyclosporin A.


The risk or severity of adverse effects can be increased when desipramine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Arotinolol is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when nalbuphine is combined with trazodone.


The risk or severity of adverse effects can be increased when suprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with halcinonide.


The risk or severity of adverse effects can be increased when clorazepate is combined with prazepam.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with procarbazine.


The risk or severity of adverse effects can be increased when Naftifine is combined with salicylamide.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when cetirizine is combined with ethotoin.


The risk or severity of adverse effects can be increased when diazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when clorazepate is combined with oxprenolol.


The risk or severity of adverse effects can be increased when gabapentin is combined with Agomelatine.


The risk or severity of adverse effects can be increased when clorazepate is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Tolcapone is combined with sotalol.


The risk or severity of adverse effects can be increased when tiagabine is combined with clomipramine.


The risk or severity of adverse effects can be increased when quinapril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when paroxetine is combined with naratriptan.


The risk or severity of adverse effects can be increased when paroxetine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Aliskiren.


The risk or severity of adverse effects can be increased when loratadine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nimodipine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with amcinonide.


The risk or severity of adverse effects can be increased when loxapine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Tramadol is combined with periciazine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when meperidine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with equilin.


The risk or severity of adverse effects can be increased when meperidine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when ketorolac is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when amphotericin b is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when nitric oxide is combined with nimodipine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with norfloxacin.


The risk or severity of adverse effects can be increased when moclobemide is combined with tiapride.


The risk or severity of adverse effects can be increased when haloperidol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with midazolam.


The risk or severity of adverse effects can be increased when nefazodone is combined with zotepine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Agomelatine.


The risk or severity of adverse effects can be increased when clonazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when metaproterenol is combined with dopamine.


The risk or severity of adverse effects can be increased when prazepam is combined with clidinium.


The risk or severity of adverse effects can be increased when sevoflurane is combined with cilazapril.


The risk or severity of adverse effects can be increased when codeine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when tizanidine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when triazolam is combined with amobarbital.


The risk or severity of adverse effects can be increased when zopiclone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Arformoterol.


The risk or severity of adverse effects can be increased when zopiclone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Limaprost is combined with Fondaparinux.


The risk or severity of adverse effects can be increased when morphine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when morphine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when amitriptyline is combined with isoproterenol.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Torasemide is combined with prazosin.


The risk or severity of adverse effects can be increased when amoxapine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when paroxetine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with dexamethasone.


The risk or severity of adverse effects can be increased when midodrine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with papaverine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with antipyrine.


The risk or severity of adverse effects can be increased when gabapentin is combined with lidocaine.


The risk or severity of adverse effects can be increased when gabapentin is combined with clemastine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when gabapentin is combined with venlafaxine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with benzocaine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when temazepam is combined with chlormezanone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with vigabatrin.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with meclizine.


The risk or severity of adverse effects can be increased when atenolol is combined with nisoldipine.


The risk or severity of adverse effects can be increased when meprobamate is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when loxapine is combined with zotepine.


The risk or severity of adverse effects can be increased when halothane is combined with acebutolol.


The risk or severity of adverse effects can be increased when levodopa is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when levodopa is combined with flunarizine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Rufinamide is combined with desipramine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with thiamylal.


The risk or severity of adverse effects can be increased when Rufinamide is combined with halothane.


The risk or severity of adverse effects can be increased when Etidocaine is combined with sertraline.


The risk or severity of adverse effects can be increased when zaleplon is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when oxaprozin is combined with alclofenac.


The risk or severity of adverse effects can be increased when gabapentin is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when tolazoline is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when gabapentin is combined with prilocaine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Eprosartan is combined with quinapril.


The risk or severity of adverse effects can be increased when gabapentin is combined with ethotoin.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when HEROIN is combined with trimipramine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when thiothixene is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when zopiclone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with trimipramine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when meprobamate is combined with cetirizine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when pimozide is combined with Normethadone.


The risk or severity of adverse effects can be increased when meprobamate is combined with protriptyline.


The risk or severity of adverse effects can be increased when lisinopril is combined with ibuprofen.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with butalbital.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with rasagiline.


The risk or severity of adverse effects can be increased when cabergoline is combined with trimipramine.


The risk or severity of adverse effects can be increased when Articaine is combined with sertraline.


The risk or severity of adverse effects can be increased when Pinaverium is combined with lovastatin.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when diltiazem is combined with carvedilol.


The risk or severity of adverse effects can be increased when zonisamide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with tretinoin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Paliperidone.


The risk or severity of adverse effects can be increased when triflupromazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with nabumetone.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with pramipexole.


The risk or severity of adverse effects can be increased when ketoprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with proparacaine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when benzocaine is combined with sertraline.


The risk or severity of adverse effects can be increased when zonisamide is combined with felbamate.


The risk or severity of adverse effects can be increased when terbinafine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with clemastine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with dextromethorphan.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when cabergoline is combined with ethanol.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when labetalol is combined with nicardipine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with linezolid.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Flibanserin.


The risk or severity of adverse effects can be increased when phenytoin is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Perospirone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with fenbufen.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Droxicam.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when aspirin is combined with Icatibant.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when pentobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with amsacrine.


The risk or severity of adverse effects can be increased when ambenonium is combined with Cevimeline.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when pargyline is combined with formoterol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when suprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when chlormezanone is combined with meclizine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when lorazepam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when lorazepam is combined with thiothixene.


The risk or severity of adverse effects can be increased when lorazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when tetracaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Retigabine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when thalidomide is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with bromazepam.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with perphenazine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with benazepril.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when reserpine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with trapidil.


The risk or severity of adverse effects can be increased when Olmesartan is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with flutamide.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Flupentixol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when chlormezanone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Tianeptine is combined with moclobemide.


The risk or severity of adverse effects can be increased when Olsalazine is combined with alclometasone.


The risk or severity of adverse effects can be increased when Tianeptine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Alogliptin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when proparacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with carisoprodol.


The risk or severity of adverse effects can be increased when rapamycin is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with prednisone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with haloperidol.


The risk or severity of adverse effects can be increased when procarbazine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Naftifine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when sevoflurane is combined with benzocaine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with vigabatrin.


The risk or severity of adverse effects can be increased when lisinopril is combined with carprofen.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Naftifine is combined with nimesulide.


The risk or severity of adverse effects can be increased when Melatonin is combined with promethazine.


The risk or severity of adverse effects can be increased when Toloxatone is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when fenoprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when morphine is combined with quinapril.


The risk or severity of adverse effects can be increased when butorphanol is combined with lidocaine.


The risk or severity of adverse effects can be increased when glutethimide is combined with tiapride.


The risk or severity of adverse effects can be increased when butorphanol is combined with clemastine.


The risk or severity of adverse effects can be increased when carprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with butorphanol.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with amcinonide.


The risk or severity of adverse effects can be increased when glutethimide is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when triamterene is combined with Riociguat.


The risk or severity of adverse effects can be increased when Butoconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when ketamine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when ethanol is combined with Retigabine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when benzoic acid is combined with nilvadipine.


The risk or severity of adverse effects can be increased when clemastine is combined with triprolidine.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when flunisolide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with leflunomide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with propofol.


The risk or severity of adverse effects can be increased when tiapride is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Clobetasone.


The risk or severity of adverse effects can be increased when tropicamide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Drospirenone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with prazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with quazepam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tetracaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Tianeptine is combined with isoetharine.


The risk or severity of adverse effects can be increased when Perospirone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when rasagiline is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when rasagiline is combined with bumetanide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when resveratrol is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when aspirin is combined with Halobetasol.


The risk or severity of adverse effects can be increased when aspirin is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when irbesartan is combined with ketorolac.


The risk or severity of adverse effects can be increased when irbesartan is combined with nabumetone.


The risk or severity of adverse effects can be increased when salicylamide is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when mepivacaine is combined with imipramine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with AMPHETAMINE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with Icatibant.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when sulindac is combined with Naftifine.


The risk or severity of adverse effects can be increased when etizolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when etizolam is combined with promethazine.


The risk or severity of adverse effects can be increased when olanzapine is combined with levorphanol.


The risk or severity of adverse effects can be increased when Paricalcitol is combined with digoxin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with nicardipine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with dantrolene.


The risk or severity of adverse effects can be increased when Flupentixol is combined with estazolam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Difenoxin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when clonidine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with levorphanol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when ketamine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when methylergonovine is combined with sulfinpyrazone.


The risk or severity of adverse effects can be increased when ketamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when lorazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with spironolactone.


The risk or severity of adverse effects can be increased when proparacaine is combined with maprotiline.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with celecoxib.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when loxapine is combined with Normethadone.


The risk or severity of adverse effects can be increased when zaleplon is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when etodolac is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when zopiclone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when rasagiline is combined with ropinirole.


The risk or severity of adverse effects can be increased when thiamylal is combined with Flibanserin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when metoprolol is combined with sotalol.


The risk or severity of adverse effects can be increased when nimodipine is combined with trandolapril.


The risk or severity of adverse effects can be increased when resveratrol is combined with DEOXYCHOLIC ACID.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Droxicam.


The risk or severity of adverse effects can be increased when estrone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with tiapride.


The risk or severity of adverse effects can be increased when vigabatrin is combined with levodopa.


The risk or severity of adverse effects can be increased when cilazapril is combined with antipyrine.


The risk or severity of adverse effects can be increased when prazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when tretinoin is combined with dipyridamole.


The risk or severity of adverse effects can be increased when prazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when ticlopidine is combined with Olsalazine.


The risk or severity of adverse effects can be increased when sotalol is combined with nadolol.


The risk or severity of adverse effects can be increased when propofol is combined with zonisamide.


The risk or severity of adverse effects can be increased when paramethasone is combined with metoclopramide.


The risk or severity of adverse effects can be increased when cilazapril is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with felbamate.


The risk or severity of adverse effects can be increased when Droxicam is combined with flumethasone.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Pramocaine.


The risk or severity of adverse effects can be increased when loxapine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cilazapril is combined with etodolac.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Demecarium.


The risk or severity of adverse effects can be increased when isoflurane is combined with penbutolol.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with oxymorphone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Butethal.


The risk or severity of adverse effects can be increased when isoflurane is combined with amobarbital.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with zopiclone.


The risk or severity of adverse effects can be increased when isoflurane is combined with lithium ion.


The risk or severity of adverse effects can be increased when isoflurane is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Etomidate.


The risk or severity of adverse effects can be increased when bromocriptine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when trandolapril is combined with quetiapine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Lofexidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Lofexidine is combined with papaverine.


The risk or severity of adverse effects can be increased when dapsone is combined with benzocaine.


The risk or severity of adverse effects can be increased when buspirone is combined with butamben.


The risk or severity of adverse effects can be increased when flurazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when miconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when pentazocine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Butethal.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with triflupromazine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with amobarbital.


The risk or severity of adverse effects can be increased when moclobemide is combined with pimozide.


The risk or severity of adverse effects can be increased when procaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when procaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Melatonin is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with lisinopril.


The risk or severity of adverse effects can be increased when Paliperidone is combined with scopolamine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when penbutolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with diclofenac.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with nylidrin.


The risk or severity of adverse effects can be increased when cocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when propantheline is combined with butorphanol.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with suprofen.


The risk or severity of adverse effects can be increased when glutethimide is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with enoxacin.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with sulindac.


The risk or severity of adverse effects can be increased when glutethimide is combined with Ramelteon.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with chloroquine.


The risk or severity of adverse effects can be increased when imipramine is combined with metolazone.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Asenapine.


The risk or severity of adverse effects can be increased when estazolam is combined with sertraline.


The risk or severity of adverse effects can be increased when ethosuximide is combined with clonazepam.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when dyclonine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when dyclonine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when triazolam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when doxepin is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when sulindac is combined with Icatibant.


The risk or severity of adverse effects can be increased when benztropine is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Propacetamol is combined with haloperidol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with prednisone.


The risk or severity of adverse effects can be increased when nimesulide is combined with aspirin.


The risk or severity of adverse effects can be increased when bepridil is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when atenolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when fosinopril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when efavirenz is combined with Difenoxin.


The risk or severity of adverse effects can be increased when prazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when ondansetron is combined with Pizotifen.


The risk or severity of adverse effects can be increased when bromazepam is combined with clozapine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Nabilone is combined with nitrendipine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when glutethimide is combined with prazepam.


The risk or severity of adverse effects can be increased when cabergoline is combined with clindamycin.


The risk or severity of adverse effects can be increased when glutethimide is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when glutethimide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when timolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when risperidone is combined with loratadine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with terazosin.


The risk or severity of adverse effects can be increased when benztropine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when thiamylal is combined with meclizine.


The risk or severity of adverse effects can be increased when halothane is combined with carvedilol.


The risk or severity of adverse effects can be increased when tolterodine is combined with tubocurarine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with hydralazine.


The risk or severity of adverse effects can be increased when tolterodine is combined with oxymorphone.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with ibudilast.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with epirizole.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when betaxolol is combined with nadolol.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with oxycodone.


The risk or severity of adverse effects can be increased when azelastine is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when temazepam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with tretinoin.


The risk or severity of adverse effects can be increased when betaxolol is combined with metolazone.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with prilocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with triazolam.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when prednisone is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when temazepam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Halazepam is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Torasemide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when prednisone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when alclofenac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when fludiazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with lithium ion.


The risk or severity of adverse effects can be increased when MELPERONE is combined with triprolidine.


The risk or severity of adverse effects can be increased when quetiapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with methocarbamol.


The risk or severity of adverse effects can be increased when amobarbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when nilvadipine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with meclizine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with zotepine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nimodipine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Apremilast.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when carprofen is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with amoxapine.


The risk or severity of adverse effects can be increased when selegiline is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with thiothixene.


The risk or severity of adverse effects can be increased when selegiline is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when rescinnamine is combined with celecoxib.


The risk or severity of adverse effects can be increased when nadolol is combined with penbutolol.


The risk or severity of adverse effects can be increased when pentobarbital is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with rasagiline.


The risk or severity of adverse effects can be increased when polythiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when floctafenine is combined with flunisolide.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with loteprednol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Tavaborole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Quinupristin.


The risk or severity of adverse effects can be increased when diltiazem is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when sevoflurane is combined with minoxidil.


The risk or severity of adverse effects can be increased when sevoflurane is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when meprobamate is combined with triprolidine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Torasemide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ketoprofen.


The risk or severity of adverse effects can be increased when tenoxicam is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when diclofenac is combined with dexamethasone.


The risk or severity of adverse effects can be increased when clorazepate is combined with estazolam.


The risk or severity of adverse effects can be increased when Trospium is combined with Metixene.


The risk or severity of adverse effects can be increased when clorazepate is combined with dantrolene.


The risk or severity of adverse effects can be increased when brotizolam is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Salsalate.


The risk or severity of adverse effects can be increased when benzocaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when indomethacin is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when haloperidol is combined with Flupentixol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when alclofenac is combined with flunisolide.


The risk or severity of adverse effects can be increased when dibucaine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when meperidine is combined with bumetanide.


The risk or severity of adverse effects can be increased when risperidone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when risperidone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with lidocaine.


The risk or severity of adverse effects can be increased when zopiclone is combined with prazepam.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Rotigotine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when brimonidine is combined with furosemide.


The risk or severity of adverse effects can be increased when methysergide is combined with ethanol.


The risk or severity of adverse effects can be increased when carbamazepine is combined with sulpiride.


The risk or severity of adverse effects can be increased when Rotigotine is combined with hydralazine.


The risk or severity of adverse effects can be increased when floctafenine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Desloratadine is combined with clonazepam.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when salicylamide is combined with betamethasone.


The risk or severity of adverse effects can be increased when pentazocine is combined with sulpiride.


The risk or severity of adverse effects can be increased when Desloratadine is combined with promethazine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with Bretylium.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when indomethacin is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when brotizolam is combined with felbamate.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with topiramate.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with Articaine.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when benzocaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with fleroxacin.


The risk or severity of adverse effects can be increased when benzocaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when spironolactone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Eprosartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with procaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with trimipramine.


The risk or severity of adverse effects can be increased when buspirone is combined with propofol.


The risk or severity of adverse effects can be increased when hydromorphone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when metoprolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when pentazocine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when pentazocine is combined with dyclonine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when alprazolam is combined with gabapentin.


The risk or severity of adverse effects can be increased when trimipramine is combined with naratriptan.


The risk or severity of adverse effects can be increased when trimipramine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when trimipramine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with fluocinonide.


The risk or severity of adverse effects can be increased when clozapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Olmesartan is combined with tolmetin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Flupentixol.


The risk or severity of adverse effects can be increased when furosemide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when triprolidine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when brotizolam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when ketorolac is combined with pentoxifylline.


The risk or severity of adverse effects can be increased when carvedilol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with dyclonine.


The risk or severity of adverse effects can be increased when temazepam is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when tiagabine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when oxiconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with nifedipine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with levodopa.


The risk or severity of adverse effects can be increased when amitriptyline is combined with sumatriptan.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with equilin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with papaverine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Azelnidipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with daunorubicin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Perospirone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when trandolapril is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when sulconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when thioridazine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with celecoxib.


The risk or severity of adverse effects can be increased when morphine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Articaine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with morphine.


The risk or severity of adverse effects can be increased when methadone is combined with meclizine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when spironolactone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when selegiline is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when pergolide is combined with hydralazine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Retigabine.


The risk or severity of adverse effects can be increased when perphenazine is combined with estazolam.


The risk or severity of adverse effects can be increased when oxazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with baclofen.


The risk or severity of adverse effects can be increased when tretinoin is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when morniflumate is combined with Olsalazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when triazolam is combined with prazepam.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with clomipramine.


The risk or severity of adverse effects can be increased when ropinirole is combined with prazosin.


The risk or severity of adverse effects can be increased when nitrazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when resveratrol is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when carvedilol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when etizolam is combined with felbamate.


The risk or severity of adverse effects can be increased when sulpiride is combined with primidone.


The risk or severity of adverse effects can be increased when butabarbital is combined with citalopram.


The risk or severity of adverse effects can be increased when midazolam is combined with diazepam.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with paroxetine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when amisulpride is combined with Etidocaine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when Perospirone is combined with protriptyline.


The risk or severity of adverse effects can be increased when Salsalate is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when fluoxetine is combined with droperidol.


The risk or severity of adverse effects can be increased when Olopatadine is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with pimozide.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when thiopental is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with sertraline.


The risk or severity of adverse effects can be increased when benzoic acid is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when clozapine is combined with enalapril.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulfathiazole.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Lacidipine.


The risk or severity of adverse effects can be increased when topiramate is combined with loratadine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when topiramate is combined with imipramine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with felbamate.


The risk or severity of adverse effects can be increased when methadone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when nicergoline is combined with colchicine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with thiothixene.


The risk or severity of adverse effects can be increased when quazepam is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when quazepam is combined with fludiazepam.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when nitric oxide is combined with methazolamide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with desipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with baclofen.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when methadone is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when clozapine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Butethal.


The risk or severity of adverse effects can be increased when methadone is combined with promethazine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with loratadine.


The risk or severity of adverse effects can be increased when ketamine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with imipramine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when acebutolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when codeine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when codeine is combined with clidinium.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with quazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with tetracaine.


The risk or severity of adverse effects can be increased when pimozide is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when mesalamine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with fenbufen.


The risk or severity of adverse effects can be increased when sulpiride is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ketoprofen.


The risk or severity of adverse effects can be increased when nitrendipine is combined with nitric oxide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when rasagiline is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when tenoxicam is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when morphine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with fluvoxamine.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with baclofen.


The risk or severity of adverse effects can be increased when temazepam is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Fospropofol is combined with tiapride.


The risk or severity of adverse effects can be increased when terbinafine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Linagliptin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with flunisolide.


The risk or severity of adverse effects can be increased when cabergoline is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when alprazolam is combined with amisulpride.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Arotinolol is combined with quinapril.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Arotinolol is combined with bumetanide.


The risk or severity of adverse effects can be increased when nalbuphine is combined with prilocaine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when levorphanol is combined with Mersalyl.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when triazolam is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when reserpine is combined with Retigabine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with primidone.


The risk or severity of adverse effects can be increased when linezolid is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with ethyl icosapentate.


The risk or severity of adverse effects can be increased when perphenazine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when perphenazine is combined with Butethal.


The risk or severity of adverse effects can be increased when Tasimelteon is combined with citalopram.


The risk or severity of adverse effects can be increased when thiothixene is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when efavirenz is combined with zonisamide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when pirenzepine is combined with pancuronium.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with propofol.


The risk or severity of adverse effects can be increased when buspirone is combined with dantrolene.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Iloperidone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when buspirone is combined with estazolam.


The risk or severity of adverse effects can be increased when pirenzepine is combined with Vecuronium.


The risk or severity of adverse effects can be increased when pirenzepine is combined with PIPECURONIUM.


The risk or severity of adverse effects can be increased when doxazosin is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Riociguat.


The risk or severity of adverse effects can be increased when ipratropium is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Apremilast is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with primidone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when methyldopa is combined with carvedilol.


The risk or severity of adverse effects can be increased when barnidipine is combined with ILOPROST.


The risk or severity of adverse effects can be increased when pentobarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with halothane.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with procaine.


The risk or severity of adverse effects can be increased when amobarbital is combined with phenytoin.


The risk or severity of adverse effects can be increased when methadone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when Halazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with trazodone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when hydromorphone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when quinapril is combined with Propacetamol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with D-mannitol.


The risk or severity of adverse effects can be increased when PONATINIB is combined with clozapine.


The risk or severity of adverse effects can be increased when suprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when enflurane is combined with Etomidate.


The risk or severity of adverse effects can be increased when suprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Tramadol.


The risk or severity of adverse effects can be increased when promazine is combined with meclizine.


The risk or severity of adverse effects can be increased when THYMOL is combined with manidipine.


The risk or severity of adverse effects can be increased when prazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when caffeine is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Aclidinium is combined with butorphanol.


The risk or severity of adverse effects can be increased when THYMOL is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Desloratadine.


The risk or severity of adverse effects can be increased when THYMOL is combined with cilnidipine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with MELPERONE.


The risk or severity of adverse effects can be increased when THYMOL is combined with Lacidipine.


The risk or severity of adverse effects can be increased when prazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with rasagiline.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when selegiline is combined with triamterene.


The risk or severity of adverse effects can be increased when alprazolam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when primidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with haloperidol.


The risk or severity of adverse effects can be increased when Melatonin is combined with Articaine.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when niflumic acid is combined with desoximetasone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when enflurane is combined with scopolamine.


The risk or severity of adverse effects can be increased when methoxamine is combined with dobutamine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Halobetasol.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with celecoxib.


The risk or severity of adverse effects can be increased when dexamethasone is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with zotepine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with ibuprofen.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with procaine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with metolazone.


The risk or severity of adverse effects can be increased when meprobamate is combined with gabapentin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with trimipramine.


The risk or severity of adverse effects can be increased when levorphanol is combined with clomipramine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when levorphanol is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when RANOLAZINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when sulpiride is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when loxapine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Metixene is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when isoflurane is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Perospirone is combined with clemastine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when testosterone propionate is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Melatonin is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Voriconazole is combined with vindesine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with carvedilol.


The risk or severity of adverse effects can be increased when thiothixene is combined with clidinium.


The risk or severity of adverse effects can be increased when trandolapril is combined with fenoprofen.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with nimesulide.


The risk or severity of adverse effects can be increased when Clofarabine is combined with terazosin.


The risk or severity of adverse effects can be increased when chloroxine is combined with Lacidipine.


The risk or severity of adverse effects can be increased when trandolapril is combined with clonidine.


The risk or severity of adverse effects can be increased when quetiapine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when dibucaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when spironolactone is combined with felodipine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with doxepin.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when Darunavir is combined with toremifene.


The risk or severity of adverse effects can be increased when morphine is combined with sotalol.


The risk or severity of adverse effects can be increased when Articaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when thioridazine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when rasagiline is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Darunavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with prednisone.


The risk or severity of adverse effects can be increased when flumethasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with ketoprofen.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when metoclopramide is combined with pilocarpine.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when procaine is combined with desipramine.


The risk or severity of adverse effects can be increased when Tiotropium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Asenapine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when cocaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when papaverine is combined with hydralazine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when butamben is combined with tiapride.


The risk or severity of adverse effects can be increased when triazolam is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when clorazepate is combined with butamben.


The risk or severity of adverse effects can be increased when oxycodone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with ambenonium.


The risk or severity of adverse effects can be increased when mesalamine is combined with Ditazole.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with butorphanol.


The risk or severity of adverse effects can be increased when butorphanol is combined with Ramelteon.


The risk or severity of adverse effects can be increased when oxycodone is combined with Melatonin.


The risk or severity of adverse effects can be increased when triprolidine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when butorphanol is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when benzoic acid is combined with bepridil.


The risk or severity of adverse effects can be increased when rapamycin is combined with bepridil.


The risk or severity of adverse effects can be increased when triamterene is combined with losartan.


The risk or severity of adverse effects can be increased when Olsalazine is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when tolazoline is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when irbesartan is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when chloroxine is combined with barnidipine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when docetaxel is combined with tretinoin.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Melatonin is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when chloroquine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with fluocinonide.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when tolbutamide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when oxycodone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when oxycodone is combined with promethazine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with trimipramine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Olopatadine.